Merck & Co., Inc. (MRK)
BMV
Closed
Aug 21, 2026
Day's Range
2,518.0052 wk Range
1,430.01Overview - MRK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
107.92T
P/E (Trailing)
‪121.97‬
PEG Ratio
‪-0.93‬
Price / Sales (TTM)
‪95.24‬
Price / Book
‪8.88‬
EV / EBITDA
‪221.24‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Held by Insiders
‪0.05%‬
Held by Institutions
‪82.72%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪2,220.58‬
200-Day Avg
‪2,036.09‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck & Co., Inc.
Peers - MRK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
- MRKBMVMerck & Co., Inc.6.36TMarket Cap+36.51%52-week change108.64P/E (Trailing)‪4.76%‬Profit Margin
- JNJBMVJohnson & Johnson11.05TMarket Cap+27.38%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- ABBVBMVAbbVie Inc.7.94TMarket Cap+13.73%52-week change75.19P/E (Trailing)‪9.80%‬Profit Margin
- ROP1NBMVRoche Holding AG6.26TMarket Cap+4.75%52-week change25.02P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSNBMVNovartis AG Sponsored ADR5.08TMarket Cap+17.59%52-week change23.70P/E (Trailing)‪22.50%‬Profit Margin
- NOVNNBMVNovartis AG4.94TMarket Cap+13.16%52-week change23.20P/E (Trailing)‪22.50%‬Profit Margin
- AZN1NBMVAstraZeneca PLC4.21TMarket Cap-9.68%52-week change23.87P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - MRK - Merck & Co., Inc.
About
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
